Analyses of molecular genomic profiling of steroidogenic factors associated with TCGA and cBioPortal research datasets revealed that abundant amplification and/or expression of the StAR gene is connected with poor survival of patients with luminal subtype breast cancer. This evidence concerns the gene STAR and breast cancer.